A/Prof P. Richmond

Peter Richmond

Telethon Institute, WA

Peter Richmond is a General Paediatrician and Paediatric Immunologist at Princess Margaret Hospital for Children and the School of Paediatrics and Child Health at the University of Western Australia. . He is also Director of Clinical Research and Education Dept of the Child and Adolescent Health Services in WA.
He is also deputy chair of the Australian Technical Advisory Group on Immunisation (ATAGI) and is a member of a number of their working groups for new vaccines. He is also on a number of other state and national committees regarding immunisation and infectious disease surveillance and Chairs 2 data safety monitoring boards for the trials of the RV3 rotavirus vaccine.

His major research interests are the development and implementation of vaccines for the prevention of meningitis, respiratory infections and otitis media. He is the director of the Vaccine Trials Group, a multidisciplinary research group whose aim is to provide a coordinated approach to the development, delivery, assessment and promotion of vaccines in our community.  This includes preclinical development of new vaccine for pertussis and Phase 1 – 4 clinical trials of paediatric and adults vaccines in WA and overseas. The group is also involved in infectious disease and vaccine adverse event surveillance, epidemiology of pneumonia and otitis media, evaluation of the WA paediatric influenza immunisation program and promoting immunisation in the community.

Other research interests include the role of innate and adaptive immunity in susceptibility to infections in preterm infants and children with recurrent otitis media and studies of the role of bacterial biofilm in otitis media and other chronic ENT infections. He is an author in over 100 scientific publications predominantly in the fields of immunisations and infectious diseases research.